Breast Surgical Service Chief Monica Morrow provides perspective on assessing the quality of surgical breast cancer treatment in an editorial in the February 1 issue of the Journal of the American Medical Association.

Recent findings by Memorial Sloan-Kettering investigators suggest it might be possible to improve the effectiveness of chemotherapy for breast cancer by combining the treatment with a new type of drug called a cathepsin inhibitor.

Research published in the November 19 issue of The Lancet finds that MRI use for breast cancer screening in women at high risk for the disease – due to family history or a genetic mutation – detects more cancers than screening mammography.